Merck plans to conduct clinical trials of a novel investigational HPV vaccine for GARDASIL9
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers
India’s first gender-neutral HPV vaccine to help reduce HPV -related disease burden in Indian girls, women and boys
Sales reflect continued strong growth in oncology and vaccines
Subscribe To Our Newsletter & Stay Updated